Skip to main content
SYBX
OTC Life Sciences

Activist Investor Proposes to Acquire Remaining Synlogic Shares for $0.64 Cash

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.595
Mkt Cap
$6.961M
52W Low
$0.54
52W High
$1.96
52W Position info
10% above low
Off High info
70% below high
Rel. Volume
Market data snapshot near publication time

SYBX is trading near its 52-week low of $0.54 (10% above the low).

Summary

A major shareholder has proposed to buy out all remaining shares of Synlogic, Inc. for $0.64 per share in cash, offering a premium and a potential path to privatization for the distressed company.


Key Events · M&A and Partnerships · SYBX

  • Acquisition Proposal Received

    Funicular Funds, LP, a 28.3% shareholder, proposed to acquire all outstanding shares of Synlogic not already owned by them for $0.64 per share in cash.

  • Premium Offer

    The non-binding offer of $0.64 per share represents a premium over the current stock price of $0.595.

  • Strategic Alternative for Distressed Company

    This proposal aligns with Synlogic's previously disclosed strategy of exploring strategic alternatives as a delisted public shell company.

  • No Financing Contingency

    Funicular Funds stated they have immediately available funds sufficient for the aggregate consideration, and the transaction would not be subject to any financing contingency.


Analysis · SYBX · Life Sciences

Funicular Funds, LP, a significant shareholder with a 28.3% stake, has submitted a non-binding proposal to acquire all outstanding shares of Synlogic, Inc. not already owned by them for $0.64 per share in cash. This offer represents a premium over the current market price of $0.595 and provides a potential exit for shareholders of the delisted "public shell company" which has been exploring strategic alternatives. The proposal, if accepted, would take the company private and offers certainty and liquidity to shareholders, aligning with the company's previously stated strategic goals.

At the time of this filing, SYBX was trading at $0.60 on OTC in the Life Sciences sector, with a market capitalization of approximately $7M. The 52-week trading range was $0.54 to $1.96. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SYBX - Latest Insights

SYBX
May 14, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.647
Real-time Price: $0.720 info
Change: +$0.073 (+11%) info
Market Cap: $8.422M info
SYBX
Mar 12, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.600
Real-time Price: $0.720 info
Change: +$0.120 (+20%) info
Market Cap: $8.422M info
SYBX
Jan 29, 2026, 9:00 AM EST
Filing Type: 8-K/A
Importance Score:
9
Price at Filing: $0.6199
Real-time Price: $0.720 info
Change: +$0.1001 (+16%) info
Market Cap: $8.422M info
SYBX
Jan 20, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.680
Real-time Price: $0.720 info
Change: +$0.040 (+6%) info
Market Cap: $8.422M info